Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Middleton

Showing results (411-420 of 480) with videos related to

Pageof 48
Sort By:
Journal of the American Chemical Society|June 10, 2016
Atomic Details of the Interactions of Glycosaminoglycans with Amyloid-β FibrilsKatie L Stewart, Eleri Hughes, Edwin A Yates, et al.
Molecular Neuropsychiatry|March 10, 2017
Analysis of Shared Haplotypes amongst Palauans Maps Loci for Psychotic Disorders to 4q28 and 5q23-q31Corneliu A Bodea, Frank A Middleton, Nadine M Melhem, et al.
International Journal of Pediatric Otorhinolaryngology|December 22, 1999
Congenital non-syndromal sensorineural hearing impairment due to connexin 26 gene mutations--molecular and audiological findingsR F Mueller, A Nehammer, A Middleton, et al.
Plos One|August 3, 2017
Analysis of SHIP1 expression and activity in Crohn's disease patientsRajesh Somasundaram, Sandra Fernandes, Jasper J Deuring, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2008
A novel 5-[1,3,4-oxadiazol-2-yl]-N-aryl-4,6-pyrimidine diamine having dual EGFR/HER2 kinase activity: design, synthesis, and biological activityTerry V Hughes, Guozhang Xu, Steven K Wetter, et al.
Journal of Medicinal Chemistry|July 8, 2005
Synthesis and identification of [1,3,5]triazine-pyridine biheteroaryl as a novel series of potent cyclin-dependent kinase inhibitorsGee-Hong Kuo, Alan Deangelis, Stuart Emanuel, et al.
Schizophrenia Research|December 11, 2013
White matter abnormalities in 22q11.2 deletion syndrome: preliminary associations with the Nogo-66 receptor gene and symptoms of psychosisMatthew D Perlstein, Moeed R Chohan, Ioana L Coman, et al.
Psychiatric Genetics|October 18, 2014
Association between autism spectrum disorder in individuals with velocardiofacial (22q11.2 deletion) syndrome and PRODH and COMT genotypesPetya D Radoeva, Ioana L Coman, Cynthia A Salazar, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|July 2, 2014
Characterizing runs of homozygosity and their impact on risk for psychosis in a population isolateNadine M Melhem, Cong Lu, Cara Dresbold, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2015
A selective small molecule NOP (ORL-1 receptor) partial agonist for the treatment of anxietyTina Morgan Ross, Kathleen Battista, Gilles C Bignan, et al.
Pageof 48

Showing results (411-420 of 480) with videos related to

Sort By:
Pageof 48
Journal of the American Chemical Society|June 10, 2016
Atomic Details of the Interactions of Glycosaminoglycans with Amyloid-β FibrilsKatie L Stewart, Eleri Hughes, Edwin A Yates, et al.
Molecular Neuropsychiatry|March 10, 2017
Analysis of Shared Haplotypes amongst Palauans Maps Loci for Psychotic Disorders to 4q28 and 5q23-q31Corneliu A Bodea, Frank A Middleton, Nadine M Melhem, et al.
International Journal of Pediatric Otorhinolaryngology|December 22, 1999
Congenital non-syndromal sensorineural hearing impairment due to connexin 26 gene mutations--molecular and audiological findingsR F Mueller, A Nehammer, A Middleton, et al.
Plos One|August 3, 2017
Analysis of SHIP1 expression and activity in Crohn's disease patientsRajesh Somasundaram, Sandra Fernandes, Jasper J Deuring, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2008
A novel 5-[1,3,4-oxadiazol-2-yl]-N-aryl-4,6-pyrimidine diamine having dual EGFR/HER2 kinase activity: design, synthesis, and biological activityTerry V Hughes, Guozhang Xu, Steven K Wetter, et al.
Journal of Medicinal Chemistry|July 8, 2005
Synthesis and identification of [1,3,5]triazine-pyridine biheteroaryl as a novel series of potent cyclin-dependent kinase inhibitorsGee-Hong Kuo, Alan Deangelis, Stuart Emanuel, et al.
Schizophrenia Research|December 11, 2013
White matter abnormalities in 22q11.2 deletion syndrome: preliminary associations with the Nogo-66 receptor gene and symptoms of psychosisMatthew D Perlstein, Moeed R Chohan, Ioana L Coman, et al.
Psychiatric Genetics|October 18, 2014
Association between autism spectrum disorder in individuals with velocardiofacial (22q11.2 deletion) syndrome and PRODH and COMT genotypesPetya D Radoeva, Ioana L Coman, Cynthia A Salazar, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|July 2, 2014
Characterizing runs of homozygosity and their impact on risk for psychosis in a population isolateNadine M Melhem, Cong Lu, Cara Dresbold, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2015
A selective small molecule NOP (ORL-1 receptor) partial agonist for the treatment of anxietyTina Morgan Ross, Kathleen Battista, Gilles C Bignan, et al.
Pageof 48